FDA licenses Acambis' ACAM2000 smallpox vaccine
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
FDA licenses Acambis' ACAM2000 smallpox vaccine

Smallpox :: FDA licenses Acambis' ACAM2000 smallpox vaccine
Acambis plc (Acambis) (LSE: ACM), a leading vaccine company, announces that the US Food and Drug Administration (FDA) has approved its ACAM2000 (Smallpox (Vaccinia) Vaccine, Live) vaccine for active immunisation against smallpox disease for persons determined to be at high risk for smallpox infection.
This approval is a key step towards Acambis finalising a long-term ?warm-base manufacturing" contract with the US Government.
Acambis developed ACAM2000 under contracts with the US Centers for Disease Control and Prevention (CDC) as part of its preparations for a public health emergency. ACAM2000, which is a single-dose vaccine, is the primary smallpox vaccine for use in an emergency and forms the majority of the US Government's smallpox vaccine Strategic National Stockpile (SNS). To date, Acambis has supplied 192.5 million doses of ACAM2000 to the CDC for the SNS.
Acambis is currently in advanced negotiations with the CDC for a ?warm-base manufacturing" contract to provide the US Government with a long-term ACAM2000 production capability that is located entirely in the US. The contract would also cover licence maintenance activities.
Ian Garland, Acambis' Chief Executive Officer, said:
?The licensure of ACAM2000 is a significant milestone not only for Acambis but also for the US Government in its plans to ensure a state of readiness against the threat of smallpox. This has been a highly successful collaboration between Acambis and the CDC, and we look forward to finalising the warm-base manufacturing contract to secure this vaccine production capability for the US Government for the long term."
(
Smallpox :: FDA licenses Acambis' ACAM2000 smallpox vaccine published at
SpiritIndia on Sunday, September 2, 2007)
Search more information on
SmallpoxRecently posted related articles on Smallpox :
- Smallpox :: New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
- Smallpox :: Australian doctor awarded for uncovering smallpox bioterrorism risk
- Smallpox :: FDA licenses Acambis' ACAM2000 smallpox vaccine
- Smallpox :: Fever after smallpox vaccination tied to individual genetic variations
- Smallpox :: Genetic factors are linked to fever following smallpox vaccination
- Smallpox :: US HHS buys next generation smallpox vaccine
- Smallpox :: U.S. HHS awards contract to Bavarian Nordic for Imvamune smallpox vaccine
- Smallpox :: Innovative smallpox vaccine research study to be conducted at Case Medical Center
- Smallpox :: US preparing for smallpox outbreak, testing vaccines to protect people
- Smallpox :: New Test May Allow for Rapid Detection of the Smallpox Virus
»»
Child Care :: Out-of-school child care subsidy rate to increase««
Lung :: Chemical culprit in popcorn worker's lung identifiedThe information provided on
SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health,
Business,
Science,
Sports,
Entertainment,
Technology
©2002-2009 SpiritIndia.com